To include your compound in the COVID-19 Resource Center, submit it here.

HER-2 DNA AutoVac: Began Phase I/II testing

Pharmexa A/S (CSE:PHARMX), Horsholm, Denmark
Product: HER-2 DNA

Read the full 85 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE